Literature DB >> 8709845

Evidence for lateral transfer and recombination in OspC variation in Lyme disease Borrelia.

I Livey1, C P Gibbs, R Schuster, F Dorner.   

Abstract

The ospC gene was amplified by the polymerase chain reaction from each of 76 Lyme disease Borrelia strains. Restriction fragment length polymorphism (RFLP) analysis demonstrated 33 distinct RFLP types; two additional RFLP types were identified from published ospC sequences. For each RFLP type, at least one ospC gene was sequenced and the degree of sequence relatedness examined by construction of an ospC gene tree. The genes were extremely diverse, with sequence identity ranging from 74.4% to 99.0%; the majority of changes are localized within the central portion of the molecule. A comparison of ospC sequences suggests that recombination occurs frequently between ospC alleles; this genetic exchange is proposed to be mediated by lateral transfer of ospC sequences. Evidence indicates that recombination occurs between ospC genes from the same Borrelia species (i.e. B. afzelii and B. garinii) as well as between different Borrelia species (i.e. B. afzelii and B. garinii, B. burgdorferi and genogroup DN127).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8709845     DOI: 10.1111/j.1365-2958.1995.mmi_18020257.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  56 in total

1.  Characterization of Borrelia burgdorferi isolated from erythema migrans lesions: interrelationship of three molecular typing methods.

Authors:  R Iyer; D Liveris; A Adams; J Nowakowski; D McKenna; S Bittker; D Cooper; G P Wormser; I Schwartz
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

2.  Cross-Immunity and Community Structure of a Multiple-Strain Pathogen in the Tick Vector.

Authors:  Jonas Durand; Maxime Jacquet; Lye Paillard; Olivier Rais; Lise Gern; Maarten J Voordouw
Journal:  Appl Environ Microbiol       Date:  2015-08-28       Impact factor: 4.792

3.  OspC phylogenetic analyses support the feasibility of a broadly protective polyvalent chimeric Lyme disease vaccine.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

4.  Characterization of Borrelia lusitaniae isolates collected in Tunisia and Morocco.

Authors:  Hend Younsi; M'Hammed Sarih; Fatima Jouda; Edmond Godfroid; Lise Gern; Ali Bouattour; Guy Baranton; Daniele Postic
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

5.  Borrelia burgdorferi B31 Erp proteins that are dominant immunoblot antigens of animals infected with isolate B31 are recognized by only a subset of human lyme disease patient sera.

Authors:  J C Miller; N El-Hage; K Babb; B Stevenson
Journal:  J Clin Microbiol       Date:  2000-04       Impact factor: 5.948

6.  The dominant epitope of Borrelia garinii outer surface protein C recognized by sera from patients with neuroborreliosis has a surface-exposed conserved structural motif.

Authors:  M J Mathiesen; A Holm; M Christiansen; J Blom; K Hansen; S Ostergaard; M Theisen
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  The rare ospC allele L of Borrelia burgdorferi sensu stricto, commonly found among samples collected in a coastal plain area of the southeastern United States, is associated with ixodes affinis ticks and local rodent hosts Peromyscus gossypinus and Sigmodon hispidus.

Authors:  Nataliia Rudenko; Maryna Golovchenko; Libor Grubhoffer; James H Oliver
Journal:  Appl Environ Microbiol       Date:  2012-12-07       Impact factor: 4.792

Review 8.  Biology of infection with Borrelia burgdorferi.

Authors:  Kit Tilly; Patricia A Rosa; Philip E Stewart
Journal:  Infect Dis Clin North Am       Date:  2008-06       Impact factor: 5.982

Review 9.  Outer membrane proteins of pathogenic spirochetes.

Authors:  Paul A Cullen; David A Haake; Ben Adler
Journal:  FEMS Microbiol Rev       Date:  2004-06       Impact factor: 16.408

10.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.